- We will send in 10–14 business days.
/images/books/11383662/9781608053131.jpg)
- Author: Maria a Miteva
- Publisher: Bentham Science Publishers
- ISBN-10: 160805313X
- ISBN-13: 9781608053131
- Format: 21.6 x 27.9 x 1.3 cm, softcover
- Language: English
- SAVE -10% with code: EXTRA
Reviews
Description
Computer-aided drug design and in silico screening have contributed to the discovery of several compounds that have either reached the market or entered clinical trials. In silico Lead Discovery is a compilation of the efforts of several experts on bioinformatics and drug design in developing the latest advances of in silico approaches for lead discovery. It contains an overview of structure-based, ligand-based methods and current fragment-based methods as well as examples for successful applications of such methods in discovering new hit/lead molecules for important therapeutic targets. Treatment of receptor flexibility - which is one of the most important challenges for in silico screening today - has also been highlighted in the Book. Biomedical scientists, biologists and chemists can find valuable information here that could help them to initiate or to complete chemical biology projects with the goal of designing new hit-to-lead molecules or chemical probes for chemogenomics projects.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 20d.22:05:59
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Author: Maria a Miteva
- Publisher: Bentham Science Publishers
- ISBN-10: 160805313X
- ISBN-13: 9781608053131
- Format: 21.6 x 27.9 x 1.3 cm, softcover
- Language: English English
Computer-aided drug design and in silico screening have contributed to the discovery of several compounds that have either reached the market or entered clinical trials. In silico Lead Discovery is a compilation of the efforts of several experts on bioinformatics and drug design in developing the latest advances of in silico approaches for lead discovery. It contains an overview of structure-based, ligand-based methods and current fragment-based methods as well as examples for successful applications of such methods in discovering new hit/lead molecules for important therapeutic targets. Treatment of receptor flexibility - which is one of the most important challenges for in silico screening today - has also been highlighted in the Book. Biomedical scientists, biologists and chemists can find valuable information here that could help them to initiate or to complete chemical biology projects with the goal of designing new hit-to-lead molecules or chemical probes for chemogenomics projects.
Reviews